483030KR market ClosedUS market —
KIWOOM 미국블록버스터바이오테크의약품+
Undervaluation
-2.23%
Premium
ETF price
₩11,787
Close
iNAV estimate
₩11,530
Trading 2.23% above the ETF's fair value (iNAV)
FX rate ₩1,341.69Anchor date 2026-09-08
Constituents
Loading estimates…
This page sets an iNAV estimate for KIWOOM 미국블록버스터바이오테크의약품+ against its Korean market quote to show the premium or discount. The guide explains how the estimate is built and where it falls short, and the fund's reference facts follow below.
Fund details
- Underlying index
- Solactive Blockbuster Biotech Drugs Index(PR)
- Manager
- Kiwoom Asset Management
- Expense ratio
- 0.49%
- Replication
- Physical (passive)
- Currency hedge
- Unhedged
- Listing date
- 2024-05-28
- Creation unit
- 50,000